Vitamin D receptor gene polymorphism as possible risk factor in rheumatoid arthritis and rheumatoid related osteoporosis

Human Immunology

Volumn 75, Issue 5, 2014, Pages 452-461

  Mosaad, Youssef M ^a   Hammad, Enas M ^a   Fawzy, Zakaria ^a   Abdal Aal, Ibrahim A ^a   Youssef, Hazem M ^a,b   ElSaid, Tamer O ^a   Monir, Rehan ^a   EL Deek, Basem S ^a,c  

^a MANSOURA UNIVERSITY   (Egypt)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

APAI PROTEIN; BIOLOGICAL MARKER; BSMI PROTEIN; C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; FOKI PROTEIN; RHEUMATOID FACTOR; TAQ POLYMERASE; TAQI POLYMERASE; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

ADULT; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MIDDLE AGED; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; CASE CONTROL STUDY; COMPLICATION; EGYPT; GENETIC POLYMORPHISM; GENETICS; MALE; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; RISK;

ADULT; ALLELES; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; EGYPT; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; RISK FACTORS;

EID: 84896543953     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.02.009     Document Type: Article

References (61)

1. Alamanos Y., Drosos A.A. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 2005, 4:130-136.
2. Kochi Y., Suzuki A., Yamada R., Yamamoto K. Genetics of rheumatoid arthritis: underlying evidence of ethnic differences. J Autoimmun 2009, 32(3-4):158-162.
3. Dieudéa P., Cornélisa F. Genetic basis of rheumatoid arthritis. Joint Bone Spine 2005, 72(6):520-526.
4. Uitterlinden A.G., Fang Y., Bergink A.P., Van Meurs J.B.J., van Leeuwen H.P.T.M., Pols H.A.P. The role of vitamin D receptor gene polymorphisms in bone biology. Mol Cell Endocrinol 2002, 197(1-2):15-21.
5. Davis C.D. Vitamin D and cancer: current dilemmas and future research needs. Am J Clin Nutr 2008, 88:565S-569S.
6. Li C., Li Y., Gao L.B., et al. Vitamin D receptor gene polymorphisms and the risk of colorectal cancer in a Chinese population. Dig Dis Sci 2009, 54:634-636.
7. Yang L., Ma J., Zhang X., Fan Y., Wang L. Protective role of the vitamin D receptor. Cell Immunol 2012, 279(2):160-166.
8. Cutolo M., Otsa K., Uprus M., Paolino S., Seriolo B. Vitamin D in rheumatoid arthritis. Autoimmun Rev 2007 Nov, 7(1):59-64. Epub 2007 Aug 14.
9. Ranganathan P. Genetics of bone loss in rheumatoid arthritis - role of vitamin D receptor polymorphisms. Rheumatology (Oxf) 2009 April, 48(4):342-346.
10. Rass P., Pákozdi A., Lakatos P., Zilahi E., Sipka S., Szegedi G., et al. Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis. Rheumatol Int 2006 Sep, 26(11):964-971.
11. Cortet B., Flipo R.M., Blanckaert F. Evaluation of bone mineral density in patients with rheumatoid arthritis, influence of disease activity and glucocorticoid therapy. Rev Rheum Eng Ed 1997, 64:451-458.
12. Henderson N.K., Sambrook P.N. Relationship between osteoporosis and arthritis and effect of corticosteroid and other drugs on bone. Curr Opin Rheumatol 1996, 8:359-365.
13. Szekanecz Z., Elek I., Bettembuk P., et al. Secondary osteoporosis in rheumatoid arthritis. Magyar Belorv Arch (Arch Int Med Hung) 1998, 51:267-271.
14. Szekanecz Z., Elek I., Szegedi G. Osteoporosis associated with rheumatoid arthritis. Ca Bone 1998, 1:45-51.
15. Szekanecz Z., Szántó S., Szabó Z., et al. Biochemical and inflammatory markers in rheumatoid arthritis and associated osteoporosis. Ca Bone 2000, 3:62-71.
16. Haussler M.R., Whitfield G.K., Haussler C.A., et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998, 13:325-349.
17. Kurt O., Yilmaz-Aydogan H., Uyar M., Isbir T., Seyhan M.F., Can A. Evaluation of ERα and VDR gene polymorphisms in relation to bone mineral density in Turkish postmenopausal women. Mol Biol Rep 2012, 39(6):6723-6730.
18. Lee Y.H., Bae S.C., Choi S.J., Ji J.D., Song G.G. Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 2011, 38:3643-3651.
19. Maalej A., Petit-Teixeira E., Michou L., Rebai A., Cornelis F., Ayadi H. Association study of VDR gene with rheumatoid arthritis in the French population. Genes Immun 2005, 6:707-711.
20. Hitchon C.A., Sun Y., Robinson D.B., Peschken C.A., Bernstein C.N., Simnovitch K.A., et al. Vitamin D Receptor polymorphism rs2228570 (Fok1) Is associated with rheumatoid arthritis in North American Natives. J Rheumatol 2012, 39:1792-1797.
21. Garcia-Lozano J.R., Gonzalez-Escribano M.F., Valenzuela A., et al. Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. Eur J Immunogenet 2001, 28:89-93.
22. Lee C.K., Hong J.S., Cho Y.S., et al. Lack of relationship between vitamin D receptor polymorphism and bone erosion in rheumatoid arthritis. J Korean Med Sci 2001, 16:188-192.
23. Ates O., Dolek B., Dalyan L., Topal-Sarikaya A. Vitamin D receptor gene polymorphisms in rheumatoid arthritis. Turk J Rheumatol 2011, 26(2):145-149.
24. Goertz B., Fassbender W.J., Williams J.C., Marzeion A.M., Bretzel R.G., Stracke H., et al. Vitamin D receptor genotypes are not associated with rheumatoid arthritis or biochemical parameters of bone turnover in German RA patients. Clin Exp Rheumatol 2003, 21:333-339.
25. Tokita A., Matsumoto H., Morrison N.A., et al. Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. J Bone Miner Res 1996, 11:1003-1009.
26. Sigurdsson G., Magnusdottir D.N., Kristinsson J.O., et al. Association of BsmI vitamin-D receptor gene polymorphism with combined bone mass in spine and proximal femur in Icelandic women. J Intern Med 1997, 241:501-505.
27. Riggs B.L., Nguyen T.V., Melton L.J., et al. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res 1995, 10:991-996.
28. Marc J., Prezelj J., Komel R., et al. Association of vitamin D receptor gene polymorphism with bone mineral density in Slovenian postmenopausal women. Gynecol Endocrinol 2000, 14:60-64.
29. Ferrari S., Rizzoli R., Chevalley T., et al. Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density. Lancet 1995, 345:423-424.
30. Houston L.A., Grant S.F., Reid D.M., et al. Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: studies in a UK population. Bone 1996, 18:249-252.
31. Zhao J., Zhou X., Meng X., et al. Polymorphisms of vitamin D receptor gene and its association with bone mineral density and osteocalcin in Chinese. Chin Med J (Engl) 1997, 110:366-371.
32. Garnero P., Borel O., Sornay-Rendu E., et al. Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: the OFELY study. J Bone Miner Res 1996, 11:827-834.
33. Ho Y.V., Briganti E.M., Duan Y., et al. Polymorphism of the vitamin D receptor gene and corticosteroid-related osteoporosis. Osteoporos Int 1999, 9:134-138.
34. Tsai K.S., Hsu S.H., Cheng W.C., et al. Bone mineral density and bone markers in relation to vitamin D receptor gene polymorphisms in Chinese men and women. Bone 1996, 19:513-518.
35. Vandevyver C., Wylin T., Cassiman J.J., et al. Influence of the vitamin D receptor gene alleles on bone mineral density in postmenopausal and osteoporotic women. J Bone Miner Res 1997, 12:241-247.
36. Aletaha D., Neogi T., Silman A.J., Funovits J., Felson D.T., Bingham C.O., et al. 2010 rheumatoid arthritis classification criteria: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 2010, 69:1580-1588.
37. van Riel P.L., Schumacher H.R. How does one assess early rheumatoid arthritis in daily clinical practice?. Best Pract Res Clin Rheumatol 2001 Mar, 15(1):67-76.
38. Prevoo M.L., van 't Hof M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B., van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38(1):44-48.
39. Cabral D., Katz J.N., Weinblatt M.E., Ting G., Avorn J., Solomon D.H. 2005: 'Development and assessment of indicators of rheumatoid arthritis severity: results of a Delphi Panel. Arthritis Rheum 2005, 53:61-66.
40. Ting G., Schneeweiss S., Scranton R., Katz J.N., Weinblatt M.E., Young M., et al. Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study. Arthritis Res Ther 2008, 10(4):R95.
41. Pincus T., Callahan L.F., Sale W.G., Brooks A.L., Payne L.E., Vaughn W.K. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984, 27:864-872.
42. World Health Organization. WHO Technical Report Series, 843. Geneva, Switzerland: WHO; 1994. Assessment of fracture risk and application to screening for postmenopausal osteoporosis.
43. Pei F.H., Wang Y.J., Gao S.L., Liu B.R., DU Y.J., Liu W., et al. Vitamin D receptor gene polymorphism and ulcerative colitis susceptibility in Han Chinese. J Dig Dis 2011, 12(2):90-98.
44. Perricone C., Ceccarelli F., Valesini G. An overview on the genetic of rheumatoid arthritis: a never-ending story. Autoimmun Rev 2011, 10(10):599-608.
45. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004, 80(6 Suppl.):1689S-1696S.
46. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357(3):266-281.
47. Monticielo Odirlei André, de Mattos Teixeira Thaisa, Bogo Chies José Artur, Tavares Brenol João Carlos, Xavier Ricardo Machado Vitamin D and polymorphisms of VDR gene in patients with systemic lupus erythematosus. Clin Rheumatol 2012 Oct, 31(10):1411-1412.
48. Cantorna M.T., Hayes C.E., DeLuca H.F. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 1998, 128:68-72.
49. Andjelkovic Z., Vojinovic J., Pejnovic N., Popovic M., Dujic A., Mitrovic D., et al. Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 1999, 17:453-456.
50. Adorini L., Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008, 4:404-412.
51. Tetlow L.C., Smith S.J., Mawer E.B., Woolley D.E. Vitamin D receptors in the rheumatoid lesion: expression by chondrocytes, macrophages, and synoviocytes. Ann Rheum Dis 1999, 58:118-121.
52. Cutolo M. Vitamin D and autoimmune rheumatic diseases. Rheumatology (Oxf) 2009, 48:210-212.
53. Suranyi P. Clinical picture of rheumatoid arthritis. Rheumatology 2001, 147-152. Medicina, Budapest. B. Gomor (Ed.).
54. Lisker R., López M., Jasqui S., de León Ponce, Rosales S., Correa-Rotter R., Sanchez S. Association of vitamin D receptor polymorphisms with osteoporosis in Mexican postmenopausal women. Hum Biol 2003, 75:399-403.
55. Horst-Sikorska W., Wawrzyniak A., Celczyńska-Bajew L., Marcinkowska M., Dabrowski S., Kalak R., Słomski R. Polymorphism of VDR gene-the most effective molecular marker of osteoporotic bone fractures risk within postmenopausal women from Wielkopolska region of Poland. Pol J Endocrinol 2005, 3:233-239.
56. Karray E.F., Ben Dhifallah I., Ben Abdelghani K. Associations of vitamin D receptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behçet's disease in Tunisians. Joint Bone Spine 2012, 79(2):144-148.
57. Kamen D.L., Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl) 2010 May, 88(5):441-450.
58. Hewison M. An update on vitamin D and human immunity. Clin Endocrinol (Oxf) 2012 Mar, 76(3):315-325.
59. Smolders J., Peelen E., Thewissen M., Menheere P., Tervaert J.W., Hupperts R., et al. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev 2009 Jun, 8(7):621-626.
60. Lucotte G., Mercier G. Brief communication: Y-chromosome haplotypes in Egypt. Am J Phys Anthropol 2003, 121:63-66.
61. Manni F., Leonardi P., Barakat A., et al. Y-chromosome analysis in Egypt suggests a genetic regional continuity in Northeastern Africa. Hum Biol 2002 Oct, 74(5):645-658.